Patents by Inventor Inna SOLODEEV

Inna SOLODEEV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mechanical apparatus and method for isolating stromal vascular fraction
    Patent number: 11891627
    Abstract: Provided is an apparatus and process for isolation of stromal vascular fraction (SVF) following lipoaspiration.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: February 6, 2024
    Assignee: THE MEDICAL RESEARCH, INFRASTRUCTURE, AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER
    Inventors: Nir Shani, Eyal Gur, Inna Solodeev, Anna Aronovich
  • GENERATION OF CYTOTOXIC TUMOR SPECIFIC CELL LINES AND USES THEREOF
    Publication number: 20180282696
    Abstract: An in-vitro method of activating T cells is disclosed. The method comprises incubating T cells with pathogenic cells in the presence of a multimeric peptide comprising at least two peptide monomers linked to one another, each of the at least two peptide monomers comprising at least 6 consecutive amino acids from the amino acid sequence as set forth in SEQ ID NO: 1, wherein the at least two peptide monomers are each no longer than 30 amino acids, wherein the multimeric peptide is capable of reducing binding of PLIF to human leukocytes under conditions which allow expansion of the T cells.
    Type: Application
    Filed: June 18, 2018
    Publication date: October 4, 2018
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Chaya MOROZ, Inna SOLODEEV
  • Generation of cytotoxic tumor specific cell lines and uses thereof
    Patent number: 10000737
    Abstract: An in-vitro method of activating T cells is disclosed. The method comprises incubating T cells with pathogenic cells in the presence of a multimeric peptide comprising at least two peptide monomers linked to one another, each of the at least two peptide monomers comprising at least 6 consecutive amino acids from the amino acid sequence as set forth in SEQ ID NO: 1, wherein the at least two peptide monomers are each no longer than 30 amino acids, wherein the multimeric peptide is capable of reducing binding of PLIF to human leukocytes under conditions which allow expansion of the T cells.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: June 19, 2018
    Assignee: Ramot at Tel-Aviv University Ltd.
    Inventors: Chaya Moroz, Inna Solodeev
  • MECHANICAL APPARATUS AND METHOD FOR ISOLATING STROMAL VASCULAR FRACTION
    Publication number: 20180155691
    Abstract: Provided is an apparatus and process for isolation of stromal vascular fraction (SVF) following lipoaspiration.
    Type: Application
    Filed: June 9, 2016
    Publication date: June 7, 2018
    Applicant: The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Nir SHANI, Eyal GUR, Inna SOLODEEV, Anna ARONOVICH
  • GENERATION OF CYTOTOXIC TUMOR SPECIFIC CELL LINES AND USES THEREOF
    Publication number: 20160122715
    Abstract: An in-vitro method of activating T cells is disclosed. The method comprises incubating T cells with pathogenic cells in the presence of a multimeric peptide comprising at least two peptide monomers linked to one another, each of the at least two peptide monomers comprising at least 6 consecutive amino acids from the amino acid sequence as set forth in SEQ ID NO: 1, wherein the at least two peptide monomers are each no longer than 30 amino acids, wherein the multimeric peptide is capable of reducing binding of PLIF to human leukocytes under conditions which allow expansion of the T cells.
    Type: Application
    Filed: February 3, 2014
    Publication date: May 5, 2016
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Chaya MOROZ, Inna SOLODEEV